Stryker Shares Outstanding 2006-2018 | SYK

Stryker shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Stryker shares outstanding for the quarter ending September 30, 2018 were 0.380B, a 0% increase year-over-year.
  • Stryker 2017 shares outstanding were 0.38B, a 0.42% increase from 2016.
  • Stryker 2016 shares outstanding were 0.379B, a 0.63% decline from 2015.
  • Stryker 2015 shares outstanding were 0.381B, a 0.5% decline from 2014.
Stryker Annual Shares Outstanding
(Millions of Shares)
2017 380
2016 379
2015 381
2014 383
2013 382
2012 383
2011 390
2010 400
2009 399
2008 414
2007 417
2006 412
2005 411
Stryker Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 380
Q2 2018 380
Q1 2018 381
Q4 2017 380
Q3 2017 380
Q2 2017 380
Q1 2017 379
Q4 2016 379
Q3 2016 379
Q2 2016 379
Q1 2016 377
Q4 2015 381
Q3 2015 381
Q2 2015 381
Q1 2015 384
Q4 2014 383
Q3 2014 383
Q2 2014 383
Q1 2014 383
Q4 2013 382
Q3 2013 382
Q2 2013 381
Q1 2013 383
Q4 2012 383
Q3 2012 383
Q2 2012 383
Q1 2012 384
Q4 2011 390
Q3 2011 388
Q2 2011 392
Q1 2011 394
Q4 2010 400
Q3 2010 398
Q2 2010 399
Q1 2010 400
Q4 2009 399
Q3 2009 400
Q2 2009 399
Q1 2009 399
Q4 2008 414
Q3 2008 416
Q2 2008 418
Q1 2008 418
Q4 2007 417
Q3 2007 418
Q2 2007 417
Q1 2007 416
Q4 2006 412
Q3 2006 412
Q2 2006 411
Q1 2006 411
Q4 2005 411
Q3 2005 411
Q2 2005 411
Q1 2005 411
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $64.588B $12.444B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $128.543B 19.22
Abbott Laboratories (ABT) United States $127.387B 25.81
Boston Scientific (BSX) United States $51.339B 25.94
Baxter (BAX) United States $35.653B 23.02
Zimmer Biomet Holdings (ZBH) United States $23.039B 14.94
Smith & Nephew SNATS (SNN) United Kingdom $16.882B 0.00
ResMed (RMD) United States $16.410B 31.29
Perrigo (PRGO) Ireland $7.997B 12.14
Bio-Rad Laboratories (BIO) United States $7.618B 48.71
Canopy Growth (CGC) Canada $7.436B 0.00
Hill-Rom Holdings (HRC) United States $6.496B 20.32
Aurora Cannabis (ACB) Canada $6.099B 32.21
Haemonetics (HAE) United States $5.365B 47.18
Insulet (PODD) United States $4.925B 0.00
ICU Medical (ICUI) United States $4.805B 26.77
Hutchison China MediTech (HCM) China $4.419B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.779B 0.00
Neogen (NEOG) United States $3.367B 50.98
Agios Pharmaceuticals (AGIO) United States $3.261B 0.00
NuVasive (NUVA) United States $2.912B 27.09
National Vision Holdings (EYE) United States $2.458B 47.55
Quidel (QDEL) United States $2.024B 26.39
NxStage Medical (NXTM) United States $1.918B 0.00
Aphria (APHA) $1.451B 0.00
Phibro Animal Health (PAHC) United States $1.321B 18.70
AtriCure (ATRC) United States $1.188B 0.00
Cardiovascular Systems (CSII) United States $1.021B 1469.50
VAREX IMAGING (VREX) United States $0.937B 18.76
PetIQ (PETQ) United States $0.858B 22.23
Surmodics (SRDX) United States $0.786B 119.80
Cerus (CERS) United States $0.780B 0.00
Meridian Bioscience (VIVO) United States $0.778B 24.78
OraSure Technologies (OSUR) United States $0.747B 42.07
Omeros (OMER) United States $0.703B 0.00
Lantheus Holdings (LNTH) United States $0.670B 20.75
Eagle Pharmaceuticals (EGRX) United States $0.661B 21.21
MacroGenics (MGNX) United States $0.605B 0.00
NanoString Technologies (NSTG) United States $0.536B 0.00
LeMaitre Vascular (LMAT) United States $0.514B 25.24
Quanterix (QTRX) United States $0.438B 0.00
Owens & Minor (OMI) United States $0.428B 4.84
TG Therapeutics (TGTX) United States $0.423B 0.00
Insys Therapeutics (INSY) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.331B 21.40
Evolus (EOLS) United States $0.327B 0.00
VAPOTHERM INC (VAPO) United States $0.307B 0.00
Cytosorbents (CTSO) United States $0.282B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.241B 0.00
Surface Oncology (SURF) United States $0.238B 0.00
Bovie Medical (BVX) United States $0.236B 0.00
BioLife Solutions (BLFS) United States $0.222B 300.25
Rockwell Medical (RMTI) United States $0.182B 0.00
Chimerix (CMRX) United States $0.172B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.142B 0.00
Fonar (FONR) United States $0.136B 6.83
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.81
Female Health (VERU) United States $0.079B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
InfuSystems Holdings (INFU) United States $0.068B 0.00
Trinity Biotech (TRIB) Ireland $0.065B 17.93
CAS Medical Systems (CASM) United States $0.053B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Neurotrope (NTRP) United States $0.030B 0.00
Myomo (MYO) United States $0.023B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Senestech (SNES) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00